Bayer CropScience
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
** Shares of India's Bayer Cropscience BAYE.NS fall as much as 2.1% to 4,212.70 rupees; stock last down 1.9%
** Revenue from operations declines 4% Y/Y in the quarter
** Corn seeds and agro-chemicals manufacturer reports June-quarter profit increases 15.4% Y/Y to 3.22 billion rupees ($33.86 million)
** 4 out of 8 analysts covering the stock rate it "buy", while 4 others rate it "hold"; median PT is 5,145.50 rupees - data compiled by LSEG
** Stock down 7.4% YTD
($1 = 95.1100 Indian rupees)
(Reporting by Payel Das in Bengaluru)
** Shares of India's Bayer Cropscience BAYE.NS fall as much as 2.1% to 4,212.70 rupees; stock last down 1.9%
** Revenue from operations declines 4% Y/Y in the quarter
** Corn seeds and agro-chemicals manufacturer reports June-quarter profit increases 15.4% Y/Y to 3.22 billion rupees ($33.86 million)
** 4 out of 8 analysts covering the stock rate it "buy", while 4 others rate it "hold"; median PT is 5,145.50 rupees - data compiled by LSEG
** Stock down 7.4% YTD
($1 = 95.1100 Indian rupees)
(Reporting by Payel Das in Bengaluru)
Aug 5 (Reuters) - Bayer Cropscience Ltd BAYE.NS:
BAYER CROPSCIENCE - PANKAJ RAMANBHAI PATEL TO CEASE AS CHAIRMAN EFFECTIVE SEPT 11, 2026
BAYER CROPSCIENCE - APPOINTS RAVI KIRPALANI AS CHAIRMAN EFFECTIVE SEPT 12, 2026
Source text: ID:nBSEJvvZk
Further company coverage: BAYE.NS
(([email protected];;))
Aug 5 (Reuters) - Bayer Cropscience Ltd BAYE.NS:
BAYER CROPSCIENCE - PANKAJ RAMANBHAI PATEL TO CEASE AS CHAIRMAN EFFECTIVE SEPT 11, 2026
BAYER CROPSCIENCE - APPOINTS RAVI KIRPALANI AS CHAIRMAN EFFECTIVE SEPT 12, 2026
Source text: ID:nBSEJvvZk
Further company coverage: BAYE.NS
(([email protected];;))
July 15 (Reuters) - Bayer Cropscience Ltd BAYE.NS:
BAYER CROPSCIENCE LTD - GETS TAX PENALTY OF 22 MILLION RUPEES
Source text: ID:nBSE27hytZ
Further company coverage: BAYE.NS
(([email protected];))
July 15 (Reuters) - Bayer Cropscience Ltd BAYE.NS:
BAYER CROPSCIENCE LTD - GETS TAX PENALTY OF 22 MILLION RUPEES
Source text: ID:nBSE27hytZ
Further company coverage: BAYE.NS
(([email protected];))
** Agrochemical products maker Bayer CropScience BAYE.NS shares rise 3.7% to 4,666.2 rupees
** The company's fourth-quarter profit rises 13.1%; revenue from operations up 5.2%
** Declares dividend of 60 rupees/share
** "While corn saw a softer season, our diversified portfolio sustained momentum," - Co
** Analysts warned that lower volumes, coupled with inflation in raw material costs due to the Middle East conflict, would exert some pressure
** Four of 8 brokerages rate the stock "Buy" or higher; their median PT is 5,218 rupees - data compiled by LSEG
** YTD, stock down 1.3% vs 4.1% decline in Nifty 500 Index .NIFTY500
(Reporting by Abhinav Parmar in Bengaluru)
(([email protected];))
** Agrochemical products maker Bayer CropScience BAYE.NS shares rise 3.7% to 4,666.2 rupees
** The company's fourth-quarter profit rises 13.1%; revenue from operations up 5.2%
** Declares dividend of 60 rupees/share
** "While corn saw a softer season, our diversified portfolio sustained momentum," - Co
** Analysts warned that lower volumes, coupled with inflation in raw material costs due to the Middle East conflict, would exert some pressure
** Four of 8 brokerages rate the stock "Buy" or higher; their median PT is 5,218 rupees - data compiled by LSEG
** YTD, stock down 1.3% vs 4.1% decline in Nifty 500 Index .NIFTY500
(Reporting by Abhinav Parmar in Bengaluru)
(([email protected];))
May 26 (Reuters) - Bayer CropScience BAYE.NS posted a 13.1% rise in fourth-quarter profit on Tuesday, as steady momentum in its herbicides and pesticides portfolio helped outweigh softer demand for corn seeds.
The Indian unit of German drugs and pesticides maker Bayer AG BAYGn.DE posted a profit of 1.62 billion rupees ($16.93 million) for the quarter ended March 31, from 1.43 billion rupees a year ago.
Here are key details:
The agrochemical company's revenue rose 5.2% to 11.01 billion rupees, while expenses rose 2.8%.
The firm said revenue growth came in below its expectations due to a challenging external environment.
"While corn saw a softer season, our diversified portfolio sustained momentum," the company said.
Analysts at Elara Capital had warned ahead of the results that lower volumes, coupled with inflation in raw material costs due to the Middle East conflict, would exert some pressure.
($1 = 95.6800 Indian rupees)
(Reporting by Mridula Kumar in Bengaluru; Editing by Janane Venkatraman)
May 26 (Reuters) - Bayer CropScience BAYE.NS posted a 13.1% rise in fourth-quarter profit on Tuesday, as steady momentum in its herbicides and pesticides portfolio helped outweigh softer demand for corn seeds.
The Indian unit of German drugs and pesticides maker Bayer AG BAYGn.DE posted a profit of 1.62 billion rupees ($16.93 million) for the quarter ended March 31, from 1.43 billion rupees a year ago.
Here are key details:
The agrochemical company's revenue rose 5.2% to 11.01 billion rupees, while expenses rose 2.8%.
The firm said revenue growth came in below its expectations due to a challenging external environment.
"While corn saw a softer season, our diversified portfolio sustained momentum," the company said.
Analysts at Elara Capital had warned ahead of the results that lower volumes, coupled with inflation in raw material costs due to the Middle East conflict, would exert some pressure.
($1 = 95.6800 Indian rupees)
(Reporting by Mridula Kumar in Bengaluru; Editing by Janane Venkatraman)
March 30 (Reuters) - Bayer Cropscience Ltd BAYE.NS:
GETS TAX PENALTY OF 29.8 MILLION RUPEES
Source text: ID:nBSE48wJ1w
Further company coverage: BAYE.NS
(([email protected];;))
March 30 (Reuters) - Bayer Cropscience Ltd BAYE.NS:
GETS TAX PENALTY OF 29.8 MILLION RUPEES
Source text: ID:nBSE48wJ1w
Further company coverage: BAYE.NS
(([email protected];;))
March 27 (Reuters) - Bayer Cropscience Ltd BAYE.NS:
BAYER CROPSCIENCE - GOT TAX ORDER IMPOSING PENALTY 11.87 MILLION RUPEES FOR FY2019-20
Source text: ID:nBSE7Glq4F
Further company coverage: BAYE.NS
(([email protected];))
March 27 (Reuters) - Bayer Cropscience Ltd BAYE.NS:
BAYER CROPSCIENCE - GOT TAX ORDER IMPOSING PENALTY 11.87 MILLION RUPEES FOR FY2019-20
Source text: ID:nBSE7Glq4F
Further company coverage: BAYE.NS
(([email protected];))
Bayer AG published a transcript of its Q4 and full-year 2025 investor call held on March 4, 2026, attended by CEO Bill Anderson, CFO Wolfgang Nickl, and the heads of Crop Science (Rodrigo Santos), Pharmaceuticals (Stefan Oelrich) and Consumer Health (Julio Triana), alongside analysts in the Q&A. Management said Bayer delivered its upgraded 2025 guidance, reporting sales of EUR 45.5 billion, core EPS of EUR 4.91 and free cash flow of EUR 2.1 billion, while continuing a company-wide transformation that has “roughly half as many layers” and “reduced management by two-thirds,” according to Anderson. The company also emphasized litigation as a key priority, referencing a proposed U.S. nationwide class settlement in glyphosate cases and a pending U.S. Supreme Court process, with Anderson stating, “We await the judge’s ruling, and we’ll be ready for any scenario.” For 2026, Bayer guided to net sales of EUR 45 billion to EUR 47 billion and EBITDA before special items of EUR 9.6 billion to EUR 10.1 billion, with core EPS of EUR 4.30 to EUR 4.80 at constant currencies. Nickl said Bayer expects negative free cash flow of minus EUR 1.5 billion to minus EUR 2.5 billion, driven by “significant litigation-related payouts of around EUR 5 billion,” and noted planned financing would rely on “senior bonds… and instruments receiving equity-credit ratings… and not on the AGM authorized capital increase.” Bayer also announced a core EPS methodology change that will include amortization of certain intangibles, particularly software. Divisionally, Crop Science discussed its profitability improvement program and licensing impacts from resolutions with Corteva, while Pharmaceuticals highlighted continued momentum in launch brands and expected declines in Xarelto and Eylea due to generics and biosimilars. Consumer Health pointed to continued market volatility in the U.S. and China but reiterated its “Road to Billion” strategy. The full transcript can be accessed through the link below.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bayer AG published the original content used to generate this news brief on March 06, 2026, and is solely responsible for the information contained therein.
Bayer AG published a transcript of its Q4 and full-year 2025 investor call held on March 4, 2026, attended by CEO Bill Anderson, CFO Wolfgang Nickl, and the heads of Crop Science (Rodrigo Santos), Pharmaceuticals (Stefan Oelrich) and Consumer Health (Julio Triana), alongside analysts in the Q&A. Management said Bayer delivered its upgraded 2025 guidance, reporting sales of EUR 45.5 billion, core EPS of EUR 4.91 and free cash flow of EUR 2.1 billion, while continuing a company-wide transformation that has “roughly half as many layers” and “reduced management by two-thirds,” according to Anderson. The company also emphasized litigation as a key priority, referencing a proposed U.S. nationwide class settlement in glyphosate cases and a pending U.S. Supreme Court process, with Anderson stating, “We await the judge’s ruling, and we’ll be ready for any scenario.” For 2026, Bayer guided to net sales of EUR 45 billion to EUR 47 billion and EBITDA before special items of EUR 9.6 billion to EUR 10.1 billion, with core EPS of EUR 4.30 to EUR 4.80 at constant currencies. Nickl said Bayer expects negative free cash flow of minus EUR 1.5 billion to minus EUR 2.5 billion, driven by “significant litigation-related payouts of around EUR 5 billion,” and noted planned financing would rely on “senior bonds… and instruments receiving equity-credit ratings… and not on the AGM authorized capital increase.” Bayer also announced a core EPS methodology change that will include amortization of certain intangibles, particularly software. Divisionally, Crop Science discussed its profitability improvement program and licensing impacts from resolutions with Corteva, while Pharmaceuticals highlighted continued momentum in launch brands and expected declines in Xarelto and Eylea due to generics and biosimilars. Consumer Health pointed to continued market volatility in the U.S. and China but reiterated its “Road to Billion” strategy. The full transcript can be accessed through the link below.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bayer AG published the original content used to generate this news brief on March 06, 2026, and is solely responsible for the information contained therein.
Bayer AG published its Annual Report 2025, outlining fiscal 2025 performance and updates across its Crop Science, Pharmaceuticals and Consumer Health divisions. The report notes that sales and earnings were affected by currency movements and litigation-related special charges, while the company continued efforts to reduce net financial debt and maintain its dividend at the legally required minimum. Bayer also highlighted progress in its operating model changes, updates on major U.S. litigations involving glyphosate and PCBs, and an outlook for 2026 that anticipates stable sales and earnings on a currency-adjusted basis, with free cash flow expected to be heavily impacted by settlement payments. The full report can be accessed through the link below.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bayer AG published the original content used to generate this news brief on March 04, 2026, and is solely responsible for the information contained therein.
Bayer AG published its Annual Report 2025, outlining fiscal 2025 performance and updates across its Crop Science, Pharmaceuticals and Consumer Health divisions. The report notes that sales and earnings were affected by currency movements and litigation-related special charges, while the company continued efforts to reduce net financial debt and maintain its dividend at the legally required minimum. Bayer also highlighted progress in its operating model changes, updates on major U.S. litigations involving glyphosate and PCBs, and an outlook for 2026 that anticipates stable sales and earnings on a currency-adjusted basis, with free cash flow expected to be heavily impacted by settlement payments. The full report can be accessed through the link below.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bayer AG published the original content used to generate this news brief on March 04, 2026, and is solely responsible for the information contained therein.
Feb 11 (Reuters) - Bayer Cropscience Ltd BAYE.NS:
BAYER CROPSCIENCE Q3 PROFIT 957 MILLION RUPEES
BAYER CROPSCIENCE Q3 REVENUE FROM OPERATIONS 11.06 BILLION RUPEES
Source text: ID:nBSE66xlHt
Further company coverage: BAYE.NS
(([email protected];;))
Feb 11 (Reuters) - Bayer Cropscience Ltd BAYE.NS:
BAYER CROPSCIENCE Q3 PROFIT 957 MILLION RUPEES
BAYER CROPSCIENCE Q3 REVENUE FROM OPERATIONS 11.06 BILLION RUPEES
Source text: ID:nBSE66xlHt
Further company coverage: BAYE.NS
(([email protected];;))
Dec 10 (Reuters) - DCM Shriram Ltd DCMS.NS:
DCM SHRIRAM LTD - CO AND BAYER SIGN MOU FOR AGRICULTURE
DCM SHRIRAM LTD - MOU ESTABLISHES FRAMEWORK FOR AGRI-INPUTS AND DIGITAL ADVISORY
DCM SHRIRAM LTD - COMPANIES TO EVALUATE PARTNERSHIP IN CHEMICALS BUSINESS
Source text: ID:nBSE7gbdyq
Further company coverage: DCMS.NS
(([email protected];;))
Dec 10 (Reuters) - DCM Shriram Ltd DCMS.NS:
DCM SHRIRAM LTD - CO AND BAYER SIGN MOU FOR AGRICULTURE
DCM SHRIRAM LTD - MOU ESTABLISHES FRAMEWORK FOR AGRI-INPUTS AND DIGITAL ADVISORY
DCM SHRIRAM LTD - COMPANIES TO EVALUATE PARTNERSHIP IN CHEMICALS BUSINESS
Source text: ID:nBSE7gbdyq
Further company coverage: DCMS.NS
(([email protected];;))
** Brokerage HSBC says strong rainfall and sowing trends support positive fundamentals for Indian agrochemical companies in the first half of FY2026
** 2025 monsoon arrived early on May 24, with an initial 31% rainfall deficit but a revival since then has pushed rainfall above average, with overall levels 2% above normal as of June 23
** Brokerage says good monsoon and higher crop sowing expected to boost seed and pesticide consumption
** HSBC maintains 'Buy' on UPL UPLL.NS and Dhanuka Agritech DHNP.NS, 'Hold' on Bayer CropScience BAYE.NS, and 'Reduce' on Rallis India RALL.NS
** YTD, UPL has gained ~29%, Dhanuka Agritech rose ~13%, Bayer CropScience edged up 1.9%, while Rallis India added 3.1%
(Reporting by Yagnoseni Das in Bengaluru)
(([email protected];))
** Brokerage HSBC says strong rainfall and sowing trends support positive fundamentals for Indian agrochemical companies in the first half of FY2026
** 2025 monsoon arrived early on May 24, with an initial 31% rainfall deficit but a revival since then has pushed rainfall above average, with overall levels 2% above normal as of June 23
** Brokerage says good monsoon and higher crop sowing expected to boost seed and pesticide consumption
** HSBC maintains 'Buy' on UPL UPLL.NS and Dhanuka Agritech DHNP.NS, 'Hold' on Bayer CropScience BAYE.NS, and 'Reduce' on Rallis India RALL.NS
** YTD, UPL has gained ~29%, Dhanuka Agritech rose ~13%, Bayer CropScience edged up 1.9%, while Rallis India added 3.1%
(Reporting by Yagnoseni Das in Bengaluru)
(([email protected];))
** Bayer CropScience BAYE.NS, a corn seeds and agrochemicals manufacturer, rises 10% to 5,650 rupees after the release of its fourth-quarter results
** Stock set for best day since September 2023, if gains hold
** BAYE's profit after tax grows 49% y/y and revenue grows 32% y/y
** Co says strong demand in the spring corn portfolio, marketing investments in Q3 and growth in crop protection drove results
** Antique Stock Broking says volume growth drove revenue and flags persisting pricing pressures
** Adds that normal monsoon forecasts and high corn prices should fuel maize seeds business growth going forward, while strong pre-monsoons will be a tailwind for the herbicide portfolio in the current quarter
** With session's gains, BAYE shares up ~9% in the last 12 months, erasing decline
(Reporting by Ananta Agarwal in Bengaluru)
** Bayer CropScience BAYE.NS, a corn seeds and agrochemicals manufacturer, rises 10% to 5,650 rupees after the release of its fourth-quarter results
** Stock set for best day since September 2023, if gains hold
** BAYE's profit after tax grows 49% y/y and revenue grows 32% y/y
** Co says strong demand in the spring corn portfolio, marketing investments in Q3 and growth in crop protection drove results
** Antique Stock Broking says volume growth drove revenue and flags persisting pricing pressures
** Adds that normal monsoon forecasts and high corn prices should fuel maize seeds business growth going forward, while strong pre-monsoons will be a tailwind for the herbicide portfolio in the current quarter
** With session's gains, BAYE shares up ~9% in the last 12 months, erasing decline
(Reporting by Ananta Agarwal in Bengaluru)
Feb 26 (Reuters) - Bayer Cropscience Ltd BAYE.NS:
BAYER CROPSCIENCE LTD - GETS TAX PENALTY OF 1.5 MILLION RUPEES
Source text: ID:nBSE9qWHC9
Further company coverage: BAYE.NS
(([email protected];;))
Feb 26 (Reuters) - Bayer Cropscience Ltd BAYE.NS:
BAYER CROPSCIENCE LTD - GETS TAX PENALTY OF 1.5 MILLION RUPEES
Source text: ID:nBSE9qWHC9
Further company coverage: BAYE.NS
(([email protected];;))
** Bayer CropScience BAYE.NS slides as much as 8.1% to 4,402 rupees, lowest since July 31, 2023
** Agricultural chemicals maker posts 63.3% y/y drop in Q3 profit on rising costs; rev up 10.7%
** Says targeted investments in promotional activities and provisions for doubtful receivables added to costs
** Stock set to fall for fourth straight session
** More than 36,000 shares traded, 2.3x the 30-day avg
** Stock rated "hold" on avg; median PT is 5,950 rupees - LSEG
** BAYE last down 6.3%, extending YTD losses to 13.8%
(Reporting by Meenakshi Maidas in Bengaluru)
(([email protected];))
** Bayer CropScience BAYE.NS slides as much as 8.1% to 4,402 rupees, lowest since July 31, 2023
** Agricultural chemicals maker posts 63.3% y/y drop in Q3 profit on rising costs; rev up 10.7%
** Says targeted investments in promotional activities and provisions for doubtful receivables added to costs
** Stock set to fall for fourth straight session
** More than 36,000 shares traded, 2.3x the 30-day avg
** Stock rated "hold" on avg; median PT is 5,950 rupees - LSEG
** BAYE last down 6.3%, extending YTD losses to 13.8%
(Reporting by Meenakshi Maidas in Bengaluru)
(([email protected];))
Feb 11 (Reuters) - Bayer Cropscience Ltd BAYE.NS:
BAYER CROPSCIENCE DEC-QUARTER PROFIT 342 MILLION RUPEES
BAYER CROPSCIENCE DEC-QUARTER REVENUE FROM OPERATIONS 10.57 BILLION RUPEES
Source text: ID:nnAPN2NCTD2
Further company coverage: BAYE.NS
(([email protected];;))
Feb 11 (Reuters) - Bayer Cropscience Ltd BAYE.NS:
BAYER CROPSCIENCE DEC-QUARTER PROFIT 342 MILLION RUPEES
BAYER CROPSCIENCE DEC-QUARTER REVENUE FROM OPERATIONS 10.57 BILLION RUPEES
Source text: ID:nnAPN2NCTD2
Further company coverage: BAYE.NS
(([email protected];;))
Jan 22 (Reuters) - Bayer Cropscience Ltd BAYE.NS:
RECEIVES PENALTY ORDER FROM CBIC MADHYA PRADESH
PENALTY IMPOSED AMOUNTS TO 19.20 MILLION RUPEES
Source text: ID:nBSE1t3DxS
Further company coverage: BAYE.NS
(([email protected];;))
Jan 22 (Reuters) - Bayer Cropscience Ltd BAYE.NS:
RECEIVES PENALTY ORDER FROM CBIC MADHYA PRADESH
PENALTY IMPOSED AMOUNTS TO 19.20 MILLION RUPEES
Source text: ID:nBSE1t3DxS
Further company coverage: BAYE.NS
(([email protected];;))
Jan 8 (Reuters) - Bayer Cropscience Ltd BAYE.NS:
BAYER CROPSCIENCE LTD - RECEIVES PENALTY ORDER FROM JOINT COMMISSIONER OF CUSTOMS & CENTRAL TAX
BAYER CROPSCIENCE LTD - PENALTY IMPOSED AMOUNTS TO 27.94 MILLION RUPEES
Source text: ID:nBSEZZlyP
Further company coverage: BAYE.NS
(([email protected];;))
Jan 8 (Reuters) - Bayer Cropscience Ltd BAYE.NS:
BAYER CROPSCIENCE LTD - RECEIVES PENALTY ORDER FROM JOINT COMMISSIONER OF CUSTOMS & CENTRAL TAX
BAYER CROPSCIENCE LTD - PENALTY IMPOSED AMOUNTS TO 27.94 MILLION RUPEES
Source text: ID:nBSEZZlyP
Further company coverage: BAYE.NS
(([email protected];;))
Nov 13 (Reuters) - Bayer Cropscience Ltd BAYE.NS:
BAYER CROPSCIENCE LTD - DIVIDEND OF 90 RUPEES PER SHARE
BAYER CROPSCIENCE SEPT-QUARTER PROFIT 1.36 BILLION RUPEES
BAYER CROPSCIENCE SEPT-QUARTER REVENUE FROM OPERATIONS 17.38 BILLION RUPEES
Source text: ID:nBSE6T1Fxk
Further company coverage: BAYE.NS
(([email protected];))
Nov 13 (Reuters) - Bayer Cropscience Ltd BAYE.NS:
BAYER CROPSCIENCE LTD - DIVIDEND OF 90 RUPEES PER SHARE
BAYER CROPSCIENCE SEPT-QUARTER PROFIT 1.36 BILLION RUPEES
BAYER CROPSCIENCE SEPT-QUARTER REVENUE FROM OPERATIONS 17.38 BILLION RUPEES
Source text: ID:nBSE6T1Fxk
Further company coverage: BAYE.NS
(([email protected];))
** Shares of Shivalik Rasayan SIVA.NS rise 13.1% to 639.9 rupees
** Agrochemicals and active pharma ingredients (API)-maker received U.S. FDA approval for its API facility in India's Gujarat state
** Stock eyes best day since July 3
** SIVA down ~14% YTD; agrochemical rivals UPL UPLL.NS and Bayer Cropscience BAYE.NS up ~4% and ~19% YTD, respectively
** Rival API-makers Aurobindo Pharma ARBN.NS and Aarti Drugs ADRG.NS up ~34% and ~6.5% YTD, respectively
(Reporting by Varun Vyas in Bengaluru)
** Shares of Shivalik Rasayan SIVA.NS rise 13.1% to 639.9 rupees
** Agrochemicals and active pharma ingredients (API)-maker received U.S. FDA approval for its API facility in India's Gujarat state
** Stock eyes best day since July 3
** SIVA down ~14% YTD; agrochemical rivals UPL UPLL.NS and Bayer Cropscience BAYE.NS up ~4% and ~19% YTD, respectively
** Rival API-makers Aurobindo Pharma ARBN.NS and Aarti Drugs ADRG.NS up ~34% and ~6.5% YTD, respectively
(Reporting by Varun Vyas in Bengaluru)
** Shares of Heranba Industries HERN.NS surge 20%, hitting upper circuit, to highest since Jan 2023
** Stock set for best day since listing on March 2021
** Agrochemical co posted Q1 profit vs yr-ago loss
** Larger rival UPL UPLL.NS posted wider-than-expected loss, Bayer Cropscience's BAYE.NS profit dropped
** HERN has now surged nearly 21% YTD, overtaking BAYE's roughly 16% gain, while UPL has lost ~4% in 2024
(Reporting by Varun Vyas in Bengaluru)
** Shares of Heranba Industries HERN.NS surge 20%, hitting upper circuit, to highest since Jan 2023
** Stock set for best day since listing on March 2021
** Agrochemical co posted Q1 profit vs yr-ago loss
** Larger rival UPL UPLL.NS posted wider-than-expected loss, Bayer Cropscience's BAYE.NS profit dropped
** HERN has now surged nearly 21% YTD, overtaking BAYE's roughly 16% gain, while UPL has lost ~4% in 2024
(Reporting by Varun Vyas in Bengaluru)
** Shares of Bayer CropScience BAYE.NS fall as much as 8.3% to 6,350 rupees; last down 4.8%
** Pesticide maker reported a near 23% fall in June-quarter profit while rev from ops dropped 6%
** BAYE set for worst session in more than two months
** Avg rating of six analysts covering the stock is "buy"; median PT at 6,060 rupees - LSEG data
** More than 142,000 shares change hands, three times the 30-day avg
** Stock up ~19% YTD, had gained 12% in 2023
(Reporting by Dimpal Gulwani in Bengaluru)
** Shares of Bayer CropScience BAYE.NS fall as much as 8.3% to 6,350 rupees; last down 4.8%
** Pesticide maker reported a near 23% fall in June-quarter profit while rev from ops dropped 6%
** BAYE set for worst session in more than two months
** Avg rating of six analysts covering the stock is "buy"; median PT at 6,060 rupees - LSEG data
** More than 142,000 shares change hands, three times the 30-day avg
** Stock up ~19% YTD, had gained 12% in 2023
(Reporting by Dimpal Gulwani in Bengaluru)
Aug 8 (Reuters) - Bayer Cropscience Ltd BAYE.NS:
BAYER CROPSCIENCE JUNE-QUARTER PROFIT 2.54 BILLION RUPEES
BAYER CROPSCIENCE JUNE-QUARTER REVENUE FROM OPERATIONS 16.31 BILLION RUPEES
Source text for Eikon: ID:nBSE37njPM
Further company coverage: BAYE.NS
(([email protected];))
Aug 8 (Reuters) - Bayer Cropscience Ltd BAYE.NS:
BAYER CROPSCIENCE JUNE-QUARTER PROFIT 2.54 BILLION RUPEES
BAYER CROPSCIENCE JUNE-QUARTER REVENUE FROM OPERATIONS 16.31 BILLION RUPEES
Source text for Eikon: ID:nBSE37njPM
Further company coverage: BAYE.NS
(([email protected];))
May 23 (Reuters) - Bayer Cropscience Ltd BAYE.NS:
BAYER CROPSCIENCE LTD - DIVIDEND OF 35 RUPEES PER SHARE
Source text for Eikon: [ID:]
Further company coverage: BAYE.NS
(([email protected];))
May 23 (Reuters) - Bayer Cropscience Ltd BAYE.NS:
BAYER CROPSCIENCE LTD - DIVIDEND OF 35 RUPEES PER SHARE
Source text for Eikon: [ID:]
Further company coverage: BAYE.NS
(([email protected];))
** Shares of agro-chemicals maker Bayer CropScience BAYE.NS down 3.6% at 5,846 rupees
** Shares dropped as much as 5.62% earlier in the session, in sharpest intraday pct loss since Sept. 16, 2022
** Indian unit of German parent Bayer AG BAYGn.DE reported a 31% fall in Q3 profit, beleaguered by sluggish demand
** Stock gained for the third straight month in January, eyes fourth consecutive qtrly gain
** More than 88,000 shares changed hands by 1:16 p.m. IST, 3.7x 30-day avg
** Mean recommendation of 7 analysts rating the stock is "buy", median PT is 5,870 rupees - LSEG data
** YTD stock has risen ~6% vs larger rival UPL's UPLL.NS 9% slide
(Reporting by Hritam Mukherjee in Bengaluru)
(([email protected];))
** Shares of agro-chemicals maker Bayer CropScience BAYE.NS down 3.6% at 5,846 rupees
** Shares dropped as much as 5.62% earlier in the session, in sharpest intraday pct loss since Sept. 16, 2022
** Indian unit of German parent Bayer AG BAYGn.DE reported a 31% fall in Q3 profit, beleaguered by sluggish demand
** Stock gained for the third straight month in January, eyes fourth consecutive qtrly gain
** More than 88,000 shares changed hands by 1:16 p.m. IST, 3.7x 30-day avg
** Mean recommendation of 7 analysts rating the stock is "buy", median PT is 5,870 rupees - LSEG data
** YTD stock has risen ~6% vs larger rival UPL's UPLL.NS 9% slide
(Reporting by Hritam Mukherjee in Bengaluru)
(([email protected];))
Feb 1 (Reuters) - Bayer Cropscience Ltd BAYE.NS:
DEC-QUARTER PROFIT 931 MILLION RUPEES VERSUS 1.35 BILLION RUPEES
DEC-QUARTER REVENUE FROM OPERATIONS 9.55 BILLION RUPEES VERSUS 10.38 BILLION RUPEES
Further company coverage: BAYE.NS
(([email protected];))
Feb 1 (Reuters) - Bayer Cropscience Ltd BAYE.NS:
DEC-QUARTER PROFIT 931 MILLION RUPEES VERSUS 1.35 BILLION RUPEES
DEC-QUARTER REVENUE FROM OPERATIONS 9.55 BILLION RUPEES VERSUS 10.38 BILLION RUPEES
Further company coverage: BAYE.NS
(([email protected];))
** Brokerage HSBC expects Indian agro input companies to recover in 2024 following a "disruptive" 2023
** Sector should rebalance over 1H2024 and may see a revival in 2H on less inventory overhang, pesticide prices close to bottoming out, higher crop prices - HSBC
** Brokerage raises PT of Dhanuka Agritech DHNP.NS to 1,200 rupees and of Bayer Cropscience BAYE.NS to 5,600 rupees
** Prefers UPL UPLL.NS, PI Industries PIIL.NS and DHNP, downgrades Rallis India RALL.NS to "reduce" from "hold"
** DHNP rises 1.6%, on track to snap six straight weeks of losses
** BAYE, UPLL, RALL, PIIL gain between 0.4% and 1.4% on Thursday
(Reporting by Hritam Mukherjee)
(([email protected];))
** Brokerage HSBC expects Indian agro input companies to recover in 2024 following a "disruptive" 2023
** Sector should rebalance over 1H2024 and may see a revival in 2H on less inventory overhang, pesticide prices close to bottoming out, higher crop prices - HSBC
** Brokerage raises PT of Dhanuka Agritech DHNP.NS to 1,200 rupees and of Bayer Cropscience BAYE.NS to 5,600 rupees
** Prefers UPL UPLL.NS, PI Industries PIIL.NS and DHNP, downgrades Rallis India RALL.NS to "reduce" from "hold"
** DHNP rises 1.6%, on track to snap six straight weeks of losses
** BAYE, UPLL, RALL, PIIL gain between 0.4% and 1.4% on Thursday
(Reporting by Hritam Mukherjee)
(([email protected];))
Bayer Cropscience Ltd BAYE.NS:
BAYER CROPSCIENCE LTD- RECEIVED AN ORDER FROM CUSTOMS, IMPOSING FINE AND PENALTIES
Source text for Eikon: ID:nBSE4kSvgY
Further company coverage: BAYE.NS
Bayer Cropscience Ltd BAYE.NS:
BAYER CROPSCIENCE LTD- RECEIVED AN ORDER FROM CUSTOMS, IMPOSING FINE AND PENALTIES
Source text for Eikon: ID:nBSE4kSvgY
Further company coverage: BAYE.NS
Dec 14 (Reuters) - Bayer Cropscience Ltd BAYE.NS:
BAYER CROPSCIENCE- GOT ORDER FROM CENTRAL GOODS & SERVICE TAX FOR DEMAND OF 8.06 MILLION RUPEES
BAYER CROPSCIENCE- DEMAND ALONG WITH PENALTY OF 8.06 MILLION RUPEES
Source text for Eikon: ID:nBSE2c3M0S
Further company coverage: BAYE.NS
(([email protected];))
Dec 14 (Reuters) - Bayer Cropscience Ltd BAYE.NS:
BAYER CROPSCIENCE- GOT ORDER FROM CENTRAL GOODS & SERVICE TAX FOR DEMAND OF 8.06 MILLION RUPEES
BAYER CROPSCIENCE- DEMAND ALONG WITH PENALTY OF 8.06 MILLION RUPEES
Source text for Eikon: ID:nBSE2c3M0S
Further company coverage: BAYE.NS
(([email protected];))
Nov 20 (Reuters) - Bayer Cropscience Ltd BAYE.NS:
CO RECEIVED ORDER FOR TAX DEMAND OF 8.55 MILLION RUPEES, PENALTY OF 8.55 MILLION RUPEES WITH INTEREST
CO TO FILE APPEAL, BELIEVES IT HAS STRONG MERITS TO CHALLENGE ORDER
Source text for Eikon: ID:nBSE3nchC6
Further company coverage: BAYE.NS
(([email protected];))
Nov 20 (Reuters) - Bayer Cropscience Ltd BAYE.NS:
CO RECEIVED ORDER FOR TAX DEMAND OF 8.55 MILLION RUPEES, PENALTY OF 8.55 MILLION RUPEES WITH INTEREST
CO TO FILE APPEAL, BELIEVES IT HAS STRONG MERITS TO CHALLENGE ORDER
Source text for Eikon: ID:nBSE3nchC6
Further company coverage: BAYE.NS
(([email protected];))
More Small Cap Ideas
See similar 'Small' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
- Business
- Financials
- Share Price
- Shareholdings
What does Bayer CropScience do?
Bayer CropScience is engaged in ‘Agri Care’ business which primarily includes manufacture, sale and distribution of insecticides, fungicides, herbicide and various other agrochemical products and production, sale and distribution of hybrid corn seeds. The company is also involved in sale and distribution of other row crop hybrid seeds. The Company’s operations include key business areas: Crop Protection, Seeds & Traits and Digital Farming.Crop Protection:The Company’s Crop Protection portfolio comprises a wide range of innovative chemical and biological pest management solutions. It also provides extensive customer service for modern and sustainable agriculture. The Company focuses on Insecticides, Fungicides, Herbicides, and Seed Growth under this category.Seeds & Traits:Bayer hybrid seeds make use of the natural genetic diversity within each crop family and can withstand environmental challenges like pests, disease, and drought while providing more choices for farmers. Bayer's product portfolio consists of hybrid seeds for crops such as corn and paddy.Digital Farming:Modern farming methods leverage technology to boost crop yields and efficiency while minimizing waste and environmental impact. These approaches use tools like remote s
Who are the competitors of Bayer CropScience?
Bayer CropScience major competitors are BASF India, Sumitomo Chem. India, Sharda Cropchem, Dhanuka Agritech, Rallis India, NACL Industries, Bhagiradha Chemicals. Market Cap of Bayer CropScience is ₹17,887 Crs. While the median market cap of its peers are ₹4,370 Crs.
Is Bayer CropScience financially stable compared to its competitors?
Bayer CropScience seems to be less financially stable compared to its competitors. Altman Z score of Bayer CropScience is 3.38 and is ranked 7 out of its 8 competitors.
Does Bayer CropScience pay decent dividends?
The company seems to pay a good stable dividend. Bayer CropScience latest dividend payout ratio is 97.72% and 3yr average dividend payout ratio is 93.81%
How has Bayer CropScience allocated its funds?
Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments
How strong is Bayer CropScience balance sheet?
Balance sheet of Bayer CropScience is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Bayer CropScience improving?
Yes, profit is increasing. The profit of Bayer CropScience is ₹732 Crs for TTM, ₹689 Crs for Mar 2026 and ₹568 Crs for Mar 2025.
Is the debt of Bayer CropScience increasing or decreasing?
The net debt of Bayer CropScience is decreasing. Latest net debt of Bayer CropScience is -₹2,843.6 Crs as of Mar-26. This is less than Mar-25 when it was -₹1,787.4 Crs.
Is Bayer CropScience stock expensive?
Bayer CropScience is not expensive. Latest PE of Bayer CropScience is 24.43, while 3 year average PE is 34.13. Also latest EV/EBITDA of Bayer CropScience is 18.44 while 3yr average is 26.15.
Has the share price of Bayer CropScience grown faster than its competition?
Bayer CropScience has given lower returns compared to its competitors. Bayer CropScience has grown at ~-6.35% over the last 6yrs while peers have grown at a median rate of 16.34%
Is the promoter bullish about Bayer CropScience?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Bayer CropScience is 71.43% and last quarter promoter holding is 71.43%.
Are mutual funds buying/selling Bayer CropScience?
The mutual fund holding of Bayer CropScience is increasing. The current mutual fund holding in Bayer CropScience is 9.23% while previous quarter holding is 9.05%.